Validation Study of Frontier X Plus (FX+) Device

计划入组 125 人 · 首次发布于 2024 年 6 月 24 日

Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma

首次发布于 2014 年 3 月 3 日

4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF

计划入组 2,011 人 · 首次发布于 2014 年 4 月 15 日

OpRegen-Plus

Euvichol-Plus

Herbmed Plus

Molecule X LLC

Mexico

OXYPROS PLUS

United States

Plus Therapeutics

United States

Ghana Receives Africa's First NovaSeq X Plus Sequencer to Address Cancer Care Disparities

Illumina Launches Protein Prep Assay to Accelerate Drug Discovery Through Large-Scale Proteomics

Precision Medicine Market Projected to Reach $456.81 Billion by 2035, Driven by AI Diagnostics and National Genomics Programs